Cargando…
Commentary: Can FXR serve as a potential target for COVID-19 prevention?
Autores principales: | Pang, Juan, Feng, Jia Nuo, Ling, Wenhua, Jin, Tianru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908566/ https://www.ncbi.nlm.nih.gov/pubmed/36785699 http://dx.doi.org/10.1016/j.apsb.2023.01.023 |
Ejemplares similares
-
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
por: Pang, Juan, et al.
Publicado: (2022) -
Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1
por: Pang, Juan, et al.
Publicado: (2023) -
Commentary: Serving the nation, serving the people: echoes of war in the early NHS
por: Bivins, Roberta
Publicado: (2020) -
Targeting the Gut Microbiota–FXR Signaling Axis for Glycemic Control: Does a Dietary Supplement Work Magic?
por: Shyng, Show-Ling
Publicado: (2017) -
Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
por: Pang, Juan, et al.
Publicado: (2021)